Inventor · disambiguated record
Steven T. Sakata
Also filed as: SAKATA STEVEN T · SAKATA Steven
11 granted patents·8 pending applications·479 citations·filing 1995–2008
93Inventor score
Top patents by PatentIndex Score
19 records- 0196US6140351AOrtho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 1998·Granted Oct 31, 2000·179 cites·50 claims
- 0293US6897231B2Indazole derivatives as JNK inhibitors and compositions and methods related theretoSIGNAL PHARM INC·Filed 2001·Granted May 24, 2005·62 cites·26 claims
- 0392US5849759ANaphthyl-substituted benzimidazole derivatives as anti-coagulantsBERLEX LAB·Filed 1995·Granted Dec 15, 1998·79 cites·14 claims
- 0491US6380221B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Apr 30, 2002·33 cites·5 claims
- 0588US7354947B2Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related theretoSIGNAL PHARM LLC·Filed 2005·Granted Apr 8, 2008·10 cites·4 claims
- 0686US7220771B2Methods of using indazole derivatives as JNK inhibitorsSIGNAL PHARM LLC·Filed 2003·Granted May 22, 2007·22 cites·4 claims
- 0785US6987184B2Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods relatedSIGNAL PHARM LLC·Filed 2002·Granted Jan 17, 2006·19 cites·4 claims
- 0884US6350761B1Benzenamine derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Feb 26, 2002·22 cites·15 claims
- 0983US7211594B2Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewithSIGNAL PHARM LLC·Filed 2003·Granted May 1, 2007·23 cites·6 claims
- 1083US7208513B2Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewithSIGNAL PHARM LLC·Filed 2004·Granted Apr 24, 2007·16 cites·12 claims
- 1183US6498185B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Dec 24, 2002·14 cites·17 claims
- 1253US2007191343A14-((4-(2-Azaperhydroepinylethoxy)phenyl)methyl)-3-2(2,4-dichlorophenyl)-7-hydroxychromen-2-one, pharmaceutically acceptable salts thereof and methods of use therewithSAKATA STEVEN T·Filed 2006·Application pending·0 cites
- 1353US2009099178A1Indazole compounds and methods of use thereofBHAGWAT SHRIPAD S·Filed 2008·Application pending·0 cites
- 1452US2007123511A1Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancerSAKATA STEVEN T·Filed 2006·Application pending·0 cites
- 1552US2004092562A1Methods for treating inflammatory conditions or inhibiting JNKSIGNAL PHARM LLC·Filed 2003·Application pending·0 cites
- 1648US2006004043A1Indazole compounds and methods of use thereofBHAGWAT SHRIPAD S·Filed 2004·Application pending·0 cites
- 1748US2005009876A1Indazole compounds, compositions thereof and methods of treatment therewithFiled 2003·Application pending·0 cites
- 1848US2005107386A1Methods of treating diseases and disorders by targeting multiple kinasesFiled 2004·Application pending·0 cites
- 1944US2008004271A1Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewithMCKENNA JEFFREY M·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven T. Sakata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →